Filipits M - Search Results

1

Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myeloma.

Filipits M, Pohl G, Stranzl T, Kaufmann H, Ackermann J, Gisslinger H, Greinix H, Chott A, Drach J. Filipits M, et al. Clin Cancer Res. 2003 Feb;9(2):820-6. Clin Cancer Res. 2003. PMID: 12576455

2

Epidermal Growth Factor Receptor T790M Mutation Testing in Non-Small Cell Lung Cancer: An International Collaborative Study to Assess Molecular EGFR T790M Testing in Liquid Biopsy.

Filipits M, Kainz V, Sebek V, Zach H, On Behalf Of The Liquid Biopsy Collaborative Study Group. Filipits M, et al. Cancers (Basel). 2023 Jul 7;15(13):3528. doi: 10.3390/cancers15133528. Cancers (Basel). 2023. PMID: 37444638 Free PMC article.

3

Expression of the lung resistance protein predicts poor outcome in de novo acute myeloid leukemia.

Filipits M, Pohl G, Stranzl T, Suchomel RW, Scheper RJ, Jäger U, Geissler K, Lechner K, Pirker R. Filipits M, et al. Blood. 1998 Mar 1;91(5):1508-13. Blood. 1998. PMID: 9473213 Free article.

4

Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer.

Roka S, Fiegl M, Zojer N, Filipits M, Schuster R, Steiner B, Jakesz R, Huber H, Drach J. Roka S, et al. Among authors: filipits m. Breast Cancer Res Treat. 1998 Mar;48(2):125-33. doi: 10.1023/a:1005937305102. Breast Cancer Res Treat. 1998. PMID: 9596484

5

Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.

Filipits M, Suchomel RW, Zöchbauer S, Brunner R, Lechner K, Pirker R. Filipits M, et al. Clin Cancer Res. 1997 Aug;3(8):1419-25. Clin Cancer Res. 1997. PMID: 9815827 Clinical Trial.

6

MRP and MDR1 gene expression in primary breast carcinomas.

Filipits M, Suchomel RW, Dekan G, Haider K, Valdimarsson G, Depisch D, Pirker R. Filipits M, et al. Clin Cancer Res. 1996 Jul;2(7):1231-7. Clin Cancer Res. 1996. PMID: 9816292

7

Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma.

Filipits M, Drach J, Pohl G, Schuster J, Stranzl T, Ackermann J, Königsberg R, Kaufmann H, Gisslinger H, Huber H, Ludwig H, Pirker R. Filipits M, et al. Clin Cancer Res. 1999 Sep;5(9):2426-30. Clin Cancer Res. 1999. PMID: 10499614 Clinical Trial.

8

The lung resistance protein (LRP) predicts poor outcome in acute myeloid leukemia.

Pirker R, Pohl G, Stranzl T, Suchomel RW, Scheper RJ, Jäger U, Geissler K, Lechner K, Filipits M. Pirker R, et al. Among authors: filipits m. Adv Exp Med Biol. 1999;457:133-9. doi: 10.1007/978-1-4615-4811-9_15. Adv Exp Med Biol. 1999. PMID: 10500788

9

MRP expression in acute myeloid leukemia. An update.

Filipits M, Stranzl T, Pohl G, Suchomel RW, Zöchbauer S, Brunner R, Lechner K, Pirker R. Filipits M, et al. Adv Exp Med Biol. 1999;457:141-50. doi: 10.1007/978-1-4615-4811-9_16. Adv Exp Med Biol. 1999. PMID: 10500789

10

Drug resistance factors in acute myeloid leukemia: a comparative analysis.

Filipits M, Stranzl T, Pohl G, Heinzl H, Jäger U, Geissler K, Fonatsch C, Haas OA, Lechner K, Pirker R. Filipits M, et al. Leukemia. 2000 Jan;14(1):68-76. doi: 10.1038/sj.leu.2401634. Leukemia. 2000. PMID: 10637479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters